22nd Century Group (XXII) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of 22nd Century Group (NASDAQ: XXII) recently:

• 12/31/2024 – 22nd Century Group was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
• 12/25/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 12/19/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 12/13/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 12/7/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 12/1/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/25/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/19/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/13/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 11/7/2024 – 22nd Century Group is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.

22nd Century Group Trading Up 5.4 %

22nd Century Group stock traded up $0.30 during mid-day trading on Friday, hitting $5.90. The company’s stock had a trading volume of 49,712 shares, compared to its average volume of 66,706. The business has a 50 day moving average price of $10.83 and a 200-day moving average price of $45.88. The company has a debt-to-equity ratio of 1.59, a current ratio of 1.09 and a quick ratio of 0.93. 22nd Century Group, Inc. has a 12 month low of $3.90 and a 12 month high of $581.85. The stock has a market cap of $3.27 million, a price-to-earnings ratio of -0.27 and a beta of 1.50.

22nd Century Group (NASDAQ:XXII) last released its earnings results on Tuesday, November 12th. The biotechnology company reported ($72.90) earnings per share for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The company had revenue of $5.95 million during the quarter.

Institutional Investors Weigh In On 22nd Century Group

An institutional investor recently bought a new position in 22nd Century Group stock. Anson Funds Management LP acquired a new position in 22nd Century Group, Inc. (NASDAQ:XXII) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 3,140,452 shares of the biotechnology company’s stock, valued at approximately $691,000. Anson Funds Management LP owned 6.77% of 22nd Century Group as of its most recent filing with the Securities and Exchange Commission. 18.06% of the stock is owned by institutional investors and hedge funds.

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.